ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42583136

Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report.

Mlayah Z and 6 others. Case Rep Hematol, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report. Papers, record 42583136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42583136

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report.
PubMed
Journal
Case Rep Hematol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mlayah ZZainebhttps://orcid.org/0009-0002-7434-5135
2Mrad KKmarhttps://orcid.org/0000-0001-7602-0751
3Ben Rekaya IInès
4Bizid IInaamhttps://orcid.org/0009-0000-2518-9987
5Slama NNaderhttps://orcid.org/0000-0002-6947-3477
6Laatiri MAMohamed Adnène
7Boukhris SSarra

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,579,283Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib.Cureus2022https://conductscience.org/library/papers/36579283PubMed
230,082,493Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?Blood2018https://conductscience.org/library/papers/30082493PubMed
332,127,639European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.Leukemia2020https://conductscience.org/library/papers/32127639PubMed
430,569,109Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress.Oncol Rep2019https://conductscience.org/library/papers/30569109PubMed
529,225,854Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case report.Clin Case Rep2017https://conductscience.org/library/papers/29225854PubMed
638,394,770Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2024https://conductscience.org/library/papers/38394770PubMed
733,883,904Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature.Onco Targets Ther2021https://conductscience.org/library/papers/33883904PubMed
828,439,970Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review.Pediatr Blood Cancer2017https://conductscience.org/library/papers/28439970PubMed
929,185,155Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia.Int J Hematol2018https://conductscience.org/library/papers/29185155PubMed
1015,054,816Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature.Am J Hematol2004https://conductscience.org/library/papers/15054816PubMed

1 to 10 of 28

See all 28 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42,583,136Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report.Case Rep Hematol2026https://conductscience.org/library/papers/42583136

Source PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
KRT2054,474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
PWWP3A84,939PubTator's text mininghttps://conductscience.org/library/genes/84939NCBI Gene
TXK7,294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42583136

GET https://conductscience.org/api/papers/v1/42583136/references?page=2

API referenceFor AI assistants